These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38832769)

  • 41. Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against
    Valentine-King MA; Cisneros K; James MO; Huigens RW; Brown MB
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MYCO WELL D-ONE detection of Ureaplasma spp. and Mycoplasma hominis in sexual health patients in Wales.
    Morris DJ; Jones LC; Davies RL; Sands K; Portal E; Spiller OB
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2427-2440. PubMed ID: 32725499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients.
    Leli C; Mencacci A; Bombaci JC; D'Alò F; Farinelli S; Vitali M; Montagna P; Bietolini C; Meucci M; Perito S; Bistoni F
    Infez Med; 2012 Jun; 20(2):82-7. PubMed ID: 22767305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon.
    Lendamba RW; Mbeang Nguema PP; Onanga R; Mombo LE
    Microb Pathog; 2022 May; 166():105528. PubMed ID: 35430268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
    Ullmann U; Schubert S; Krausse R
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.
    Waites KB; Duffy LB; Bébéar CM; Matlow A; Talkington DF; Kenny GE; Totten PA; Bade DJ; Zheng X; Davidson MK; Shortridge VD; Watts JL; Brown SD
    J Clin Microbiol; 2012 Nov; 50(11):3542-7. PubMed ID: 22915608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.
    Bebear CM; Renaudin H; Charron A; Gruson D; Lefrancois M; Bebear C
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2557-60. PubMed ID: 10952617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
    Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum Associated With Specific Genital Symptoms and Clinical Signs in Nonpregnant Women?
    Plummer EL; Vodstrcil LA; Bodiyabadu K; Murray GL; Doyle M; Latimer RL; Fairley CK; Payne M; Chow EPF; Garland SM; Bradshaw CS
    Clin Infect Dis; 2021 Aug; 73(4):659-668. PubMed ID: 33502501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of genital infections caused by Mycoplasma hominis, M. genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000-2019).
    Moridi K; Hemmaty M; Azimian A; Fallah MH; Khaneghahi Abyaneh H; Ghazvini K
    BMC Public Health; 2020 Jun; 20(1):1020. PubMed ID: 32600306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey.
    Karabay O; Topcuoglu A; Kocoglu E; Gurel S; Gurel H; Ince NK
    Clin Exp Obstet Gynecol; 2006; 33(1):36-8. PubMed ID: 16761537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiological investigation and antimicrobial susceptibility analysis of ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations.
    Song T; Ye A; Xie X; Huang J; Ruan Z; Kong Y; Song J; Wang Y; Chen J; Zhang J
    J Clin Pathol; 2014 Sep; 67(9):817-20. PubMed ID: 24982440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3776-8. PubMed ID: 18663020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
    Beeton ML; Chalker VJ; Jones LC; Maxwell NC; Spiller OB
    Antimicrob Agents Chemother; 2016 Jan; 60(1):52-6. PubMed ID: 26459899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Antimicrobial Susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Female Outpatients, 2017 - 2021.
    Zheng LQ; Wang QY
    Clin Lab; 2023 May; 69(5):. PubMed ID: 37145085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
    Piccinelli G; Gargiulo F; Biscaro V; Caccuri F; Caruso A; De Francesco MA
    Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility of mixed infection of Ureaplasma Urealyticum and Mycoplasma Hominis to seven antimicrobial agents and comparison with that of Ureaplasma Urealyticum infection.
    Huang C; Liu Z; Lin N; Tu Y; Li J; Zhang D
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):203-5. PubMed ID: 12973952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital Mycoplasma infections and their resistance phenotypes in an African setting.
    Kouegnigan Rerambiah L; Ndong JC; Medzegue S; Elisee-Ndam M; Djoba Siawaya JF
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1087-90. PubMed ID: 25630539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.